# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-039902
Filing Date
2023-05-15
Accepted
2023-05-15 17:00:58
Documents
62
Period of Report
2023-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | f10q0323_actiniumphar.htm iXBRL | 10-Q | 757367
2 | CERTIFICATION | f10q0323ex31-1_actiniumphar.htm | EX-31.1 | 9885
3 | CERTIFICATION | f10q0323ex31-2_actiniumphar.htm | EX-31.2 | 9861
4 | CERTIFICATION | f10q0323ex32-1_actiniumphar.htm | EX-32.1 | 3876
5 | CERTIFICATION | f10q0323ex32-2_actiniumphar.htm | EX-32.2 | 3999
11 | GRAPHIC | img_001.jpg | GRAPHIC | 107444
12 | GRAPHIC | img_002.jpg | GRAPHIC | 75776
13 | GRAPHIC | img_003.jpg | GRAPHIC | 102316
14 | GRAPHIC | img_004.jpg | GRAPHIC | 109947
15 | GRAPHIC | img_005.jpg | GRAPHIC | 54781
16 | GRAPHIC | img_006.jpg | GRAPHIC | 93305
17 | GRAPHIC | img_007.jpg | GRAPHIC | 83065
18 | GRAPHIC | img_008.jpg | GRAPHIC | 54526
19 | GRAPHIC | img_009.jpg | GRAPHIC | 78582
20 | GRAPHIC | img_010.jpg | GRAPHIC | 44595
21 | GRAPHIC | img_011.jpg | GRAPHIC | 60287
22 | GRAPHIC | img_012.jpg | GRAPHIC | 79135
23 | GRAPHIC | img_013.jpg | GRAPHIC | 123469
| Complete submission text file | 0001213900-23-039902.txt |  | 6205378

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | atnm-20230331.xsd | EX-101.SCH | 39601
7 | XBRL CALCULATION FILE | atnm-20230331_cal.xml | EX-101.CAL | 23571
8 | XBRL DEFINITION FILE | atnm-20230331_def.xml | EX-101.DEF | 153701
9 | XBRL LABEL FILE | atnm-20230331_lab.xml | EX-101.LAB | 341812
10 | XBRL PRESENTATION FILE | atnm-20230331_pre.xml | EX-101.PRE | 170304
56 | EXTRACTED XBRL INSTANCE DOCUMENT | f10q0323_actiniumphar_htm.xml | XML | 251458

Mailing Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017
Business Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017 (646) 677-3870
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 23923954
SIC: 2834 Pharmaceutical Preparations